Earlier work in this Laboratory has established conditions for the formation of methionine, from homocysteine plus serine or formaldehyde, by soluble enzyme systems extracted from Eseherichia coli. A cofactor of the folic acid group* is essential, and with E. coli PA 15 an extract of the heated organisms, H4PtG3 and its N5-and N'0-formyl derivatives are all effective. H4PtG inhibits competitively the action of both H4PtG3 and the extract of heated E. coli (Szulmajster & Woods, 1960; Jones, Guest & Woods, 1961) ; such inhibition does not, however, occur if cobalamin is added either to the ultrasonic extracts or to the medium on which the organisms are grown (Kisliuk & Woods, 1960;  Guest, Helleiner, Cross & Woods, 1960) . With ultrasonic extracts of E. coli 121/176 (an auxotroph requiring cobalamin or methionine for growth) cobalamin is essential even when H4PtG3 (or extract of heated E. coli) is present. Cobalamin acts after conversion into a complex factor (Kisliuk & Woods, 1960; which has been purified from strain PA15 and shown to be a cobamide-containing enzyme (Foster, Jones & Woods, 1961a;  Kisliuk, 1961) . Analogues of cobalamin inhibit the formation of the cobamide-containing enzyme from cobalamin or 5,6-dimethylbenzimidazolylcobamide coenzyme, but are without effect on the activity of extracts of organisms grown in the presence ofadded cobalamin (Guest, 1960) and presumably possessing the cobamide-containing enzyme.
The enzymic synthesis of methionine from homocysteine and serine with H4PtG as cofactor has also been studied in E. coli 113/3 (another cobalamin or methionine auxotroph) and found to require a cobamide-containing enzyme which is formed from cobalamin and an apoenzyme present in extracts of autotrophic organisms grown in the absence of cobalamin (Hatch, Takeyama & Buchanan, 1959; Hatch, Cathou & Larrabee, 1960; Takeyama & Buchanan, 1960) .
Extracts of mammalian liver form methionine with H4PtG (or its N5-formyl derivative) as * Abbreviations for members of the folic acid group, based on PtG for pteroylglutamate: H4PtG, tetrahydropteroylmonoglutamate; H4PtG3, tetrahydropteroyltriglutamate; derivatives of these compounds are indicated as, c.g., AT5N'0-methylene-H4PtG.
cofactor (Nakao & Greenberg, 1958; Stevens & Sakami, 1959) ; evidence was obtained by Wilmanns, Rucker & Jaenicke (1960) that H4PtG itself acts as the hydrogen donor for the formation of the methyl group of methionine and N5-methyldihydropteroylmonoglutamate (N5-methyl-H2PtG) was proposed as an intermediate. There was no requirement for cobalamin in these mammalian systems.
The present study was undertaken to clarify further the relationship between cobalamin and folic acid in the synthesis of methionine by E. coli. By using several strains of E. coli that grew with methionine but not with homocysteine, i.e. each unable to bring about the overall reaction, a successful search was made for further enzymes (apart from the cobamide-containing enzyme) that might take part. Evidence is presented for two distinct and alternative enzymic mechanisms for the methylation of homocysteine. One is catalysed by an enzyme (A) plus the cobamide-containing enzyme and the other by the enzyme A plus a third enzyme (B). H4PtG is active in the first system, but not in the second, which has a specific requirement for H4PtG3. Brief reports of part of the present work have been made by Foster, Tejerina & Woods (1961b) and Guest & Woods (1962a) .
While this work was in progress, an enzyme concerned in the methylation of homocysteine by extracts of E. coli 113/3 and absent from E. coli 205/2 (an auxotroph requiring p-aminobenzoic acid and methionine) was described by Hatch, Larrabee, Cathou & Buchanan (1961) . Preparations of this enzyme catalysed the formation, from N5N10-methylene-H4PtG and NADH2, of an intermediate which was used for the methylation of homocysteine by preparations of the cobamide-containing enzyme in the presence of ATP, FAD, NADH2 and Mg2+ ions (Larrabee & Buchanan, 1961) .
MATERIALS AND METHODS
Organisms and enzyme-containing extracts. E. coli strain Pa 15 is an auxotroph requiring either serine or glycine for growth; it was originally obtained from Dr Barbara Wright and the parent strain was isolated from sewage (B. E.
Wright, personal communication). E. coli strains 121/176 and 113/3 were both auxotrophs requiring methionine or cobalamin for growth, and were derived from the prototrophic strain W (Davis & Mingioli, 1950 Organisms weregrown on solid defined media in enamelled trays as described by (1960) modified by the use of 20 mM-potassium phosphate buffer, pH 7-8, containing 2-mercaptoethanol (7 mM) both for the preparation of suspensions of organisms before ultrasonic treatment and for the dialysis of the extracts. Extracts of acetone-dried organisms (strain PA15) were prepared as described by Jones et al. (1961) .
Both types of extract were sometimes treated with Dowex 1 resin (X8; C1 form; 100-200 mesh) by the method of Kisliuk & Woods (1960) . The protein and nucleic acid content of extracts was determined spectrophotometrically according to Layne (1957) .
An extract of heated E. coli, containing natural forms of folic acid, was prepared from acetone-dried organisms of strain PA 15 (grown in the absence of added cobalamin) as described by .
All extracts were stored at -200 and lost no activity over a period of 6 months.
Test for methionine fornation. The conditions used for testing methionine synthesis were based on previous work in this Laboratory. The basal reaction mixture contained, in a final volume of 1 or 2 ml.: potassium phosphate buffer (pH 7.8), 120 mM; DL-homocysteine, 6-7 mM; L-serine, 5 mM; ATP, 5 mm; glucose, 20 mM; MgSO4, 5 mM; NAD, 0 5 mM; FMN, 0-25 mM; pyridoxal phosphate, 0 5 mM; 2-mercaptoethanol, 4 mm; enzyme preparation equivalent to 5-6 mg. of protein/ml. In some experiments glucose was replaced by a NADH2-generating system consisting of ethanol (10 mM) and crystallized yeast alcohol dehydrogenase (30,pg./ml. (1961 a) through its ability to promote methionine synthesis (by extracts of acetone-dried organisms of strain PA 15 grown without cobalamin) in a reaction mixture containing H4PtG as folic acid coenzyme.
Preparations of purified cobamide-containing enzyme were made from acetone-dried organisms of strain PA 15 grown in the presence of cobalamin by a modification of the method ofFoster et al. (1961 a) . Crudeextractsweretreated with CaCl2, subjected to isoelectric precipitation and treated with protamine sulphate as described originally, but in the column chromatography of the enzyme with protamine on Celite 545 the removal of inert protein with 120 mMpotassium phosphate buffer, pH 7-8, was continued until 500 ml. (instead of 120 ml.) had passed through before eluting the enzyme with 160 mM-potassium phosphate buffer, pH 7-8. The remaining four steps of the purification were omitted. This procedure gave a preparation with the same degree of purification (150-fold), but in a yield (6% overall) double that of the original method. Batches of purified enzyme were used on the day the preparation was completed.
Assay of cobalamin. Materials were first suspended or dissolved in 20 mM-potassium phosphate, pH 6-5, containing potassium cyanide (1-10 mM) and autoclaved (for 10 min. at 1150). After digestion for 48 hr. at 250 under aseptic conditions with papain (final concn. 300 ,g./ml.; sterilized by Seitz-filtration), the mixture was adjusted to pH 4-5 with acetic acid and heated at 1000 for 10 min. The supernatant fluid, after centrifuging, was used for the assay of cobalamin with Euglena gracitis var. bacillaris by the procedure of Kisliuk & Woods (1960) . Growth was assessed in an EEL photoelectric colorimeter (Evans Electroselenium Ltd., Halstead, Essex) with red filter no. 608, or by measuring (in a Unicam SP. 600 spectrophotometer) the extinctions at 420 m, and 670 mu of the pigments extracted with ethyl acetate (Epstein & Weiss, 1960) . Standard cobalamin was prepared according to Foster et al. (1961 a) ; none of the test materials influenced the response of the organism to added cobalamin. Results are corrected for the recovery (90-100%) of cobalamin added to control tubes in the preparation of the test samples. With purified cobamide-containing enzyme the elaborate treatment of samples to release cobalamin was unnecessary and the more rapid (though less sensitive) procedure of Foster et al. (1961 a) with E. coli 113/3 as assay organism was used.
Chemicals. H4PtG was prepared as described by Kisliuk & Woods (1960) and stored as the solid under H2. H4PtG3
was prepared according to the method of Jones et al. (1961) from pteroyl-y-glutamyl-y-glutamylglutamic acid (PtG,) 
RESULTS
Activation by the cobamide-containing enzyme of extracts of a cobalamin/methionine auxotroph Ultrasonic extracts of strain 121/176 methylate homocysteine with H4PtG as cofactor only if cobalamin is present; the latter is presumed to act after conversion into a cobamide-containing enzyme . Purified cobamidecontaining enzyme (from strain PA 15 grown in the presence of cobalamin) has now been shown to activate the ultrasonic extract of strain 121/176 in the presence of H4PtG, H4PtG3 or the extract of heated E. coli (Table 1) . In the one case tested (H4PtG), activation by the cobamide-containing enzyme was more than ten times as efficient as that by cobalamin when activities were compared in terms of the cobalamin content of the enzyme. Further, the action of the cobamide-containing enzyme was not inhibited by the anilide analogue of cobalamin at a concentration that completely inhibited the action of cobalamin itself (Table 1) .
Methionine synthesis by mixtures of extracts from different strains Ultrasonic extracts of strain 3/62 (an auxotroph requiring methionine for growth), and of strains 121/176 and 113/3 (responding either to cobalamin or methionine), harvested after growth with methionine, each failed to synthesize methionine when the folic acid cofactor was either the extract of heated E. coli or H4PtG3 (Table 2 ). However, mixtures of such extracts derived from strains 3/62 and 121/176 (or from strains 3/62 and 113/3) were highly active with either the extract of heated E. coli or H4PtG3. With H4PtG no single extract or combination of two extracts was active. The ability to use the monoglutamate as cofactor was, with strains 121/176 and 113/3 (and mixtures containing them), dependent on the addition of cobalamin (Table 2, last column); even then the synthesis of methionine was relatively low. Cobalamin did not activate extracts of strain 3/62 under any conditions tested.
It is clear that the metabolic lesion in strain 3/62 is distinct from that in strains 121/176 and 113/3, and that the defect in the latter strains is probably the same.
Two further important points emerge from the results obtained with mixed extracts of strains 3/62 and 121/176. First, methionine is not formed when the folic acid cofactor is H4PtG and hence strain 3/62 cannot be providing the cobamide-containing enzyme. Secondly, the synthesis obtained with H4PtG3 or the extract of heated E. coli as cofactor is about ten times as great as that obtained with 121/176 extract and a cofactor system of H4PtG plus cobalamin.
Maximum methionine synthesis by mixtures of extracts of strains 3/62 and 121/176 (or 113/3) was obtained with equal amounts of protein from each strain (Fig. 1) . Since the extract of strain 113/3 behaved in a quantitatively similar manner to that from strain 121/176, it appears that not only are the strains identical with respect to the enzyme supplied by them in the present test system (i.e. the enzyme missing from strain 3/62), but also that both lack the enzyme which can be supplied by strain 3/62. Strain 121/176 was chosen for further work since more background information about it in relation to methionine synthesis was available in this Laboratory. The results of Fig. 1 Table 3 ). Other requirements, with either the extract of heated E. coli or H4PtG3 as cofactor, were similar to those reported for strain PA 15 by . Negligible synthesis occurred when homocysteine, serine or pyridoxal phosphate was omitted, and the addition of cobalamin was without effect (Table 3) . Maximum synthesis required Mg2+ ions, NAD, glucose, ATP and anaerobic conditions. Glucose was not needed if a NADH2-generating system was added (Table 3 ). In previous work in this Laboratory with strain PA 15 a requirement for FMN had been observed (Foster et al. 1961a; Guest & Woods, 1962 b) . Under the present conditions FAD increased synthesis by about 30 % (Table 3) . When the mixed extract (after dialysis and treatment with Dowex 1 resin) was filtered through Sephadex G-50 (Kisliuk, 1960 ) the effect was sharpened and the omission of FAD resulted in a 70 % decrease in methionine synthesis; FMN only partially replaced FAD.
Since extracts of either strain 3/62 or 121/176 contain the enzyme (serine hydroxymethyltransferase) catalysing the transfer of the hydroxymethyl group of serine to H4PtG or H4PtG3, the results obtained so far established an a priori case that the overall transfer (with concomitant reduction) of the hydroxymethyl group from reduced folic acid to homocysteine, in the absence of added cobalamin, requires at least two enzymes. One of Protein from strain 3/62 (%) Successful fractionation of larger amounts of fraction I was achieved by applying the principles of the method devised by Foster et al. (1961a) for the purification of the cobamide-containing enzyme, i.e. precipitation of the enzyme with protamine, reelution of the enzyme-protamine complex from the precipitate and chromatography on Celite 545. Dialysed fraction I (900 mg. of protein in 90 ml. of 20 mM-potassium phosphate buffer, pH 7.0) was treated with 4-5 ml. of protamine sulphate (20 mg./ ml.) and with 2 g. of Celite 545. The suspension was 31 poured into a column (4 cm.2 x 2-5 cm.) and the effluent run through a larger Celite 545 column (6-5 cm.2 x 30 cm.) previously washed with the 20 mm buffer. Passage of 80 mM-potassium phosphate buffer, pH 7-0, through both columns transferred enzyme A to the larger column; after the upper column had been discarded and the removal of some protein from the lower one with 155 mmrpotassium phosphate buffer, pH 7 0, the enzyme was eluted with 250 mM-potassium phosphate buffer, pH 7 0. A typical chromatographic separation is shown in Fig. 3 . The pooled active fractions from the Celite colurmn contained 25-45 units of enzyme A activity/mg. of protein, and when dialysed against 10 mM-potassium phosphate buffer, pH 7 0, yielded a precipitate containing the enzyme. Successive extraction of this with 10 ml. portions of 20 mm-, 50 mM-and 80 mM-potassium phosphate buffer, pH 7 0, resulted in a final solution containing 80 units of enzyme/mg. of protein. After the addition of serum albumin (5 mg./ml.) the product (fraction III) was stored at -200 for up to 3 weeks before use. Data at different stages of purification by the larger-scale procedure are given in Purification. Crude extracts of strain 3/62 contained 0-8-1-2 units of enzyme B/mg. of protein; extracts of other strains of E. coli (PA15, B, 518 and K 12) contained less enzyme B, and strain 3/62 was therefore chosen for preparative work. Crude undialysed extract (50 ml.; 20 mg. of protein/ml.) was treated with protamine sulphate (8-75 ml.; 20 mg./ml. in 20 mM-potassium phosphate buffer, pH 7-8); over 90 % of the nucleic acid and 60 % of the protein was removed without loss of enzyme activity (Fig. 4) . The supernatant fluid after centrifuging was submitted to column chromatography on DEAE-cellulose equilibrated with 20 mmpotassium phosphate buffer, pH 7-8; a salt gradient up to 590 mM-potassium chloride in 120 mM-potassium phosphate buffer, pH 7-8, was used for elution (Fig. 5) . Reproducible results were not obtained with batches of the cellulose that had been regenerated after use in other experiments. The pooled fractions of highest specific activity were dialysed overnight against two changes of 5 mM-potassium phosphate buffer, pH 7-8, and then diluted with the same buffer so as to decrease the protein content to 0-7 mg./ml. Some inactive protein was removed by adsorption on to alumina Cy gel (0-75 ml. of gel/100 ml. of solution) before adsorption of the active protein on to the same gel (5 ml. of gel/100 ml. of the supernatant from the first gel treatment). The enzyme was eluted with two portions (50 ml.) of 20 mt-potassium phosphate, pH 7-8; the product at this stage had a specific activity of 10-15 units of enzyme B/mg. of protein. The gel eluate could be concentrated without loss ofactivity by adsorbing the protein on to a column (1-5 cm.2 x 1-5 cm.) of DEAE-cellulose (equilibrated with 20 mM-potassium phosphate, pH 7-8) and eluting it with 10 ml. of 590 mm-potassium chloride in 120 mM-potassium phosphate buffer, pH 7-8. The product was stored at 0-4°. The results at various stages of purification are given in Table 5 .
Further fractionation of the product by precipitation with ammonium sulphate, by isoelectric precipitation, by chromatography on CM-cellulose or by adsorption and elution from calcium phosphate gel did not increase the relatively low degree of purification achieved.
Propertie8. The material activating 121/176 extract was assumed to be enzymic since it was non-diffusible and thermolabile; 50 % of the The supernatant fluid after protamine treatment (52 ml. containing 380 mg. of protein and 1300 units of enzyme B) was chromatographed on DEAE-cellulose as described in the text; 5 ml. fractions were collected. Protein (-) was measured for each fraction; points are omitted for clarity. 0, Enzyme B concn.; ----, salt gradient. the two enzymes was not high, these results diminish the possibility that a further enzyme or enzymes is required for the overall reaction.
In similar experiments, N5N'0-methylene-H4PtG was substituted for the triglutamate derivative as direct source of the C1 residue. There was no significant formation of methionine with mixtures of either crude (Table 6 ) or purified (Table 7 ) preparations of enzymes A and B, or in systems in which the source of one enzyme was crude and the other purified; the failure with the crude preparations is therefore unlikely to be due to the presence of an inhibitory factor. There was, however, considerable methionine formation when a source of the cobamide-containing enzyme was added during the second stage of the incubation (Expt. 2 in Table 6 ). To make conditions as comparable as possible the cobamide-containing enzyme was provided as an extract of strain 3/62 itself, but from organisms grown in the presence of cobalamin; the extract thus contained, besides cobamide-containing enzyme, all the materials present in the normal 3/62 extract used as source of enzyme B. It is concluded that enzyme A can also form from N5N10-methylene-H4PtG a heat-stable intermediate, but that the further reaction of this with homocysteine is not catalysed by enzyme B, but only by the cobamide-containing-enzyme system. Distinction between the cobamide-containing enzyme and enzyme B It is clear from the work described above that enzyme B is sharply differentiated from the cobamide-containing enzyme in that only H4PtG3 is effective with the former whereas the monoglutamate is also active with the latter. However, since, when H4PtG3 (or the extract of heated E. coli) is used as cofactor, 121/176 extracts can form methionine if supplemented either with enzyme B or with the cobamide-containing enzyme, it was important to obtain further evidence of difference between the two enzymes.
The purified enzyme B preparation, even after treatment to release bound cobalamin, had barely detectable activity in promoting the growth of Euglena gracitli and was at the extreme lower limit of the assay for cobalamin. Assuming such activity to be due to cobalamin, enzyme B contained at most less than one-hundred-thousandth as much cobalamin as the cobamide-containing enzyme, i.e. 45 pug./mg. of protein compared with the value of 0 55,g. reported for the purified cobamidecontaining enzyme by Foster et al. (1961 a) ; both values relate, of course, to the present state of purification of the two enzymes. Further, purified enzyme B had no cobamide-containing-enzyme activity when assayed in the usual way with extracts of acetone-dried organisms of strain PA 15 grown in the absence of added cobalamin and with H4PtG as cofactor.
The non-identity of the two enzymes was also made clear by the titration with protamine sulphate of an extract of strain 3/62 prepared from organisms grown in the presence of cobalamin and thus possessing both the cobamide-containing enzyme and enzyme B. The cobamide-containing enzyme can be assayed separately from enzyme B because it is active with H4PtG as cofactor whereas enzyme B is not. The precipitation of the cobamide-containing enzyme, which required relatively small amounts of protamine sulphate, followed a sigmoid curve (Fig. 6) . Any assay for enzyme B (which requires H4PtG3) will, however, also assay the cobamidecontaining enzyme, since the latter is also active with H4PtG3. The precipitation of enzyme B from a source free from the cobamide-containing enzyme requires larger amounts of protamine sulphate (Fig. 4) than does the cobamide-containing enzyme. Table 7 . Formation of methionine by purified preparations of enzymes A and B Purified enzyme A (fraction III; 24,g./ml.) or 121/176 extract (5 mg. of protein/ml.) was first incubated anaerobically for 1-5 hr. with formaldehyde (3 3 mM), plus either H4PtG3 or H4PtG (3 3 mM), serum albumin (5 mg./ml.) and the reaction mixture given in Table 6 . After heating for 7 min. at 650, the mixture was incubated a further 1-5 hr. with homocysteine (6-7 mM) and either purified enzyme B (75 ,ug./ml.) or extract of strain 3-62 (5 mg. of protein/ml.) When both enzymes are present in the same extract a diphasic precipitation curve would be expected, the first part corresponding to the curve for the cobamide-containing enzyme and the second to the later precipitation of enzyme B. Such a curve was, in fact, obtained (Fig. 6) .
Purified cobamide-containing enzyme was stable for at least 2 hr. at 00 in 4*5M-ammonium sulphate at pH 7-8, but protamine-treated extract of strain 3/62 lost 75 % of its enzyme B activity within 30 min. under the same conditions. Purified enzyme B was even more sensitive than the cobamidecontaining enzyme to treatment with cyanide; 50 % of the activity was lost in 30 min. at 220 and pH 8 with 0 07 mi-potassium cyanide, whereas 50 % inactivation of the cobamide-containing enzyme required 2-2 mM-potassium cyanide under the same conditions (Foster et al. 1961 count of the organisms indicated that this value corresponded to less than half a molecule of cobalamin per organism.
DISCUSSION
For the sake of clarity in interpreting the results, tetrahydropteroyltriglutamate (H4PtG3) is taken to include the active factors present in the extract of heated E. coli; there is good evidence (Jones et al. 1961; Guest & Woods, 1962a ) that one of these is the N5-formyl derivative of H4PtG3.
E. coli 3/62 (derived from strain 518) is an auxotroph responding for growth only to methionine and not to homocysteine or cobalamin. As expected cell-free extracts do not convert homocysteine into methionine in the presence of substrates and cofactors effective with extracts of strains (e.g. PA 15) having no growth requirement for methionine. The enzyme (A) lacking in this mutant can be supplied by extracts of other strains of E. coli, including 121/176 and 113/3 which are auxotrophs with a growth response to either methionine or cobalamin. Such activation by enzyme A occurs only with H4PtG3, and not with H4PtG unless cobalamin is also added; this is in accordance with previous results with strain PA 15, which is competent to synthesize methionine, where H4PtG was an effective cofactor only when cobalamin was provided (Kisliuk & Woods, 1960; . The activation of extract of strain 3/62 to convert homocysteine into methionine under standard conditions provided means of estimating enzyme A; it was thus possible to assay a single enzymic component of a complex system of enzymes without knowledge of the nature of that enzyme or its primary product. An assay of this kind would, of course, also detect an apoenzyme or any other enzyme in the test material able to fulfil the function of the enzyme under test; nevertheless this approach might be expected in general to give information about the individual reactions of a multi-enzyme sequence. A purification of enzyme A was achieved by using this assay method, but the final product may represent an apoenzyme rather than an intact holoenzyme.
The purification of enzyme A from strain 121/176, and of enzyme B from strain 3/62, rather than from strains competent to synthesize methionine, is of interest for three reasons. First, the crude extracts to be assayed are themselves unable to form methionine from homocysteine and serine, thus avoiding any uncertainty about subtraction of endogenous methionine synthesis. Secondly, each enzyme preparation is automatically freed of at least one enzyme related to it in metabolic function, e.g. enzyme A is free of enzyme B. Finally, the auxotrophic strains were a richer source of each 485 Vol. 92 enzyme than prototrophic strains; this is probably a result (Foster, Rowbury & Woods, 1963) of harvesting the auxotrophs after prolonged growth in a medium with a poor supply of methionine, i.e. conditions where relief from repression might occur (Gorini & Maas, 1958) .
Incubation of N5N'0-methylene-H4PtG3 (representing the product of serine hydroxymethyltransferase action on serine) with enzyme A, either purified or present in a crude extract of strain 121/ 176, leads to the accumulation of a thermostable product (X3); this gives methionine on subsequent incubation with homocysteine and either purified enzyme B or an extract of strain 3/62 grown with methionine (i.e. containing enzyme B but neither the cobamide-containing enzyme nor enzyme A). Similarly, N5N10-methylene-H4PtG leads to an intermediate (X1), but here subsequent conversion into methionine with homocysteine requires the cobamide-containing enzyme, provided as an extract of strain 3/62 grown with both methionine and cobalamin. The characterization of X1 and X3 as the N5-methyl derivatives of H4PtG and H4PtG3 respectively, together with the demonstration of the requirements for their synthesis by enzyme A, is described by Guest, Foster & Woods (1964a) . The present results demonstrate clearly that the metabolic lesion in the auxotrophs responding to methionine alone occurs earlier in the biosynthetic sequence than the lesion in auxotrophs responding alternatively to methionine or to cobalamin.
As expected from previous studies in this Laboratory, methionine synthesis by an extract of strain 121/176, prepared from organisms grown with methionine, can be promoted more efficiently by the purified cobamide-containing enzyme than by cobalamin. Activation by the cobamide-containing enzyme occurs with either H4PtG or H4PtG3 as cofactor and, unlike activation by cobalamin, is not blocked by the anilide analogue of cobalamin. However, the extract of strain 121/176 can also be activated to form methionine by extracts of other strains of E. colti (e.g. 3/62) even when each strain used had been grown without added cobalamin. Such activation cannot be via the cobamide-containing enzyme since the effect is found with H4PtG3 only; H4PtG is inhibitory and its use as an effective cofactor still requires that cobalamin be added.
The requirements for methionine synthesis by mixtures of extracts of strain 3/62 and 121/176 are similar to those described for strain PA 15 or strain 113/3 (Hatch et al. 1961) . The functions of these cofactors have been investigated and are described and discussed by Guest et al. (1964a) and Guest, Friedman, Foster, Tejerina & Woods (1964b) .
Taken as a whole, the present results, together with the demonstration of the formation of the cobamide-containing enzyme by strains PA 15, 3/62 and 121/176 , show that E. coti (or strains PA 15, 518 and W at least) can methylate homocysteine by two different enzymic mechanisms (Scheme 1). In the absence of added cobalamin, C-3 of serine is converted into the methyl group of methionine via serine hydroxymethyltransferase, enzyme A and enzyme B with H4PtG3 as cofactor (pathway c). When cobalamin is available, a second mechanism can operate by using the cobamide-containing enzyme as an alternative to enzyme B (pathway b). Although in 
both mechanisms H4PtG3 can be used as cofactor, H4PtG is effective in only the cobalamin-dependent mechanism (pathway a) and inhibits pathway c. Mutation to loss of enzyme A gives an auxotroph responding to methionine alone, but mutation to loss of enzyme B gives an auxotroph responding to either methionine or cobalamin. That two pathways exist is also supported by earlier findings in this Laboratory. A requirement for cobalamin in methionine synthesis by extracts of E. coli has been found only when either (a) the extracts were derived from cobalamin auxotrophs ), or (b) when H4PtG rather than H4PtG3 was used as a cofactor with any of the strains tested (Kisliuk & Woods, 1960; Jones et al. 1961) . Further, H4PtG actually inhibits the function of H4PtG3, derivatives of which occur naturally. Finally, although cobalamin analogues inhibit the growth (on cobalamin) of cobalamin auxotrophs, they do not inhibit the growth of strains not requiring the vitamin (Guest, 1960) .
The assay developed for enzyme B, analogous to that for enzyme A, enabled sufficient purification of the enzyme to show that it is distinct from the cobamide-containing enzyme (e.g. in terms of cobalamin content) even though the two enzymes act alternatively when H4PtG3 is the cofactor. Since all the known cobalamin auxotrophs of E. coli will also grow when supplied with methionine, it follows that cobalamin should not be present in any strain grown in its absence if the normal mechanism of methionine synthesis is independent of cobalamin. This was supported by the finding that strain PA 15 contains negligible amounts of growthpromoting activity for Euglena gracili8 (even after treatment to release the vitamin as cyanocobalamin), and certainly no more than the cobalamin auxotroph grown with methionine. Thus it is concluded that cobalamin auxotrophs such as 121/176 or 113/3 have not, as has been generally supposed (e.g. Hatch et al. 1961) , lost the ability to synthesize cobalamin, but have lost enzyme B and are therefore dependent on cobalamin being provided and the ability to synthesize the cobamidecontaining enzyme. The synthesis of methionine via enzyme B can be considered the constitutive pathway; the cobalamin system represents an adaptive mechanism evoked by the provision of cobalamin. SUMMARY 1. The formation of methionine from homocysteine has been studied by using mixtures of cellfree extracts of methionine auxotrophs of E8cher-ichia colti blocked between homocysteine and methionine and giving growth responses (a) only with methionine or (b) with methionine or cobalamin. Methionine formation occurred only when extracts of type (a) and (b) auxotrophs were mixed, and it was deduced that each auxotroph lacks an enzyme present in the other.
2. Enzyme A, present in the methionine/cobalamin auxotroph, and also in methionine-independent strains of E. coli, has been purified 80-fold. It catalyses the formation of heat-stable intermediates, Xl and X3, from N5N'0-methylenetetrahydropteroyl-monoglutamate and -triglutamate respectively.
3. Enzyme B catalyses a reaction between X3
(though not X,) and homocysteine, yielding methionine. It has been purified 15-fold from extracts of an auxotroph responding to methionine only and is also present in strains competent to synthesize methionine. 4. Methionine formation from homocysteine and X, requires a cobamide-containing enzyme present in methionine/cobalamin auxotrophs and other strains of E. coli only when they are grown in the presence of cobalamin. This enzyme can also use X3 as substrate. 5. Enzyme B is free from the cobamidecontaining enzyme, contains a negligible amount of cobalamin and can be separated from the cobamidecontaining enzyme when both are present in the same extract. 6. A strain of E. coli fully competent to synthesize methionine when harvested from a medium devoid of cobalamin was found to contain a negligible amount of cobalamin.
7. It is concluded that methionine formation normally occurs through the successive action of enzymes A and B, is independent of cobalamin, but requires specifically tetrahydropteroyltriglutamate as cofactor. Growth in the presence of cobalamin evokes a second mechanism, obligatory for methionine/cobalamin auxotrophs, that depends on a cobamide-containing enzyme though either tetrahydropteroyl-monoglutamate or -triglutamate serves as cofactor. The term folate is used in this paper in reference to both simple and conjugated members of the folic acid family of vitamins; tetrahydrofolate thus includes both 5,6,7,8-tetrahydropteroyl-monoglutamate and -triglutamate.*
Methyl Derivatives of Folic
The general background of the present work was fully reviewed in the preceding paper (Foster, Tejerina, Guest & Woods, 1964) , in which was also presented experimental evidence that there are alternative pathways for the conversion of homocysteine into methionine by strains of E8cherichia coli. These differ in the mechanism by which the C, unit is transferred (with concomitant reduction) from N5N'0-methylenetetrahydrofolate to homocysteine (Scheme 1 in Foster et al. 1964 ). In one case only N5N'0-methylene-H4PtG3 could be used as substrate; it was converted by an enzyme A into an unidentified intermediate (X3) that reacted with homocysteine in the presence of an enzyme B; cobalamin derivatives were not required at either step. The alternative mechanism was dependent on a cobamide-containing enzyme, clearly distinguishable from enzyme B. In this case the N5N'0-methylene derivative of either H4PtG or H4PtG3 was an effective substrate and they were converted by enzyme A into intermediates X1 and X3 respectively; both X1 and X3 yielded methionine when incubated with homocysteine and an enzymic extract possessing the cobamide-containing enzyme but not enzyme B.
The object ofthe present work was to identify the intermediates X1 and X3 and to study in more detail the mechanism of their formation by enzyme A. E. colti 121/176 (an auxotroph giving a growth response with either methionine or cobalamin) was used as a specific source of this enzyme since it lacks enzyme B and possesses no cobamide-containing enzyme when grown with methionine (Table 1) .
The technique used for the identification of X1 (and consequently of X3) was aided by the publica-* Abbreviations for members of the folic acid group, based on PtG for pteroylglutamate: H4PtG, tetrahydropteroylmonoglutamate; H4PtG3, tetrahydropteroyltriglutamate; H2PtG, dihydropteroylglutamate; derivatives of these compounds are indicated as, e.g., N5N10-methyleneH4PtG, N5-methyl-H4PtG3.
